Showing results (691-700 of 1,044) with videos related to

Sort By:
Pageof 105
Cancer Chemotherapy and Pharmacology|March 14, 2024
The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancersAllison Dunn, Naoko Takebe, Alice Chen, et al.
Journal of Perinatal Medicine|February 21, 2014
Imaging of fetal thymus in pregnant women with rheumatic diseasesAnn-Christin Warby, Susanne Amler, Annett M Jacobi, et al.
Human Reproduction (Oxford, England)|March 22, 2021
The ellagic acid metabolites urolithin A and B differentially affect growth, adhesion, motility, and invasion of endometriotic cells in vitroBarbara Mc Cormack, N Maenhoudt, V Fincke, et al.
Molecular Cancer|July 19, 2014
Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signalingChristof Bernemann, Carolin Hülsewig, Christian Ruckert, et al.
Standards in Genomic Sciences|February 8, 2017
Complete genome sequence of <i>Pseudoalteromonas</i> phage vB_PspS-H40/1 (formerly H40/1) that infects <i>Pseudoalteromonas</i> sp. strain H40 and is used as biological tracer in hydrological transport studiesRené Kallies, Bärbel Kiesel, Matthias Schmidt, et al.
Clinical Neuropathology|October 30, 2019
Multicentric malignant glioma with striking morphologic heterogeneity and early and extensive metastatic spread to the boneNadine Peter, Thomas Roetzer, Julia Furtner, et al.
Cancer Chemotherapy and Pharmacology|May 14, 2024
Non-linear IV pharmacokinetics of the ATR inhibitor berzosertib (M6620) in miceJoshua J Deppas, Brian F Kiesel, Jianxia Guo, et al.
Archives of Gynecology and Obstetrics|November 22, 2024
Supportive care and information needs in relation to quality of life among patients with breast cancer and gynaecological cancer during the time of treatmentSaskia-Laureen Herbert, A S Payerl, M Prange, et al.
Journal of Cancer Research and Clinical Oncology|July 22, 2021
Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21<sup>WAF1/CIP1</sup>Fabian M Troschel, Heike Palenta, Katrin Borrmann, et al.
Clinical Orthopaedics and Related Research|May 28, 2015
What Risk Factors Are Associated With Musculoskeletal Injury in US Army Rangers? A Prospective Prognostic StudyDeydre S Teyhen, Scott W Shaffer, Robert J Butler, et al.
Pageof 105